Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK furthers enquiry into EU R&D (research and development) commitment:

This article was originally published in Clinica

Executive Summary

The director general of the UK's Research Councils, Dr John Taylor, has been summoned to give evidence in the parliamentary enquiry into the cost-effectiveness of the UK's involvement in the EU's science and technology research programmes on April 9 2003. The enquiry by the House of Commons' Science and Technology Committee is focusing on issues ranging from whether the UK government is doing enough to promote participation in the sixth framework programme (FP6) to whether the selection of priority areas and the awarding of funding is appropriate (see Clinica No 1036, p 5). FP6, spanning 2002-06, has a budget of E17.5bn ($19bn).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT061497

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel